- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05638048
Effect of Precise Grip Strength Training on PICC Catheter-Related Thrombosis in Cancer Patients
December 1, 2022 updated by: Junyan Zhao
In this study, color Doppler ultrasound diagnostic instrument and electronic grip device were used to determine the best grip strength of patients with tumor PICC catheterization, formulate precise and standardized grip strength training guidance for them, provide personalized functional exercise health education, and observe the impact of precise grip strength training guidance on Peripheral central venous catheter-associated thrombosis.
To provide a reference for clinical prevention of Peripheral central venous catheter-associated thrombosis in the future.
Study Overview
Status
Active, not recruiting
Study Type
Interventional
Enrollment (Actual)
270
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shandong
-
Jinan, Shandong, China, 250000
- Qianfoshan Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Cancer patients undergoing chemotherapy throughout their treatment in our hospital
- Patients with PICC implanted for the first time and maintained at our hospital;
- Age 18-60 years;
- Normal cognitive function;
- the clenching movement is barrier-free;
- The material and performance of PICC catheter are silicone three-way valve catheter;
- Catheter placement under the guidance of portable color Doppler ultrasound diagnostic instrument;
- Voluntarily participate and sign the informed consent form.
Exclusion Criteria:
- Patients treated with combined radiotherapy;
- Patients with coagulation dysfunction;
- Patients who need to use anticoagulant drugs due to underlying diseases;
- Puncture times more than 1 time;
- The blood flow velocity of catheterization vessel in calm state was less than 4.78cm/s.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: The control group
Patients were routinely implanted with PICC and received routine health education.
The content of health education included face-to-face language explanation of the whole process of catheter knowledge, issuing catheter maintenance manual, issuing ordinary grip ball and telling how to use it, and follow-up.
|
Patients were routinely implanted with PICC and received routine health education.
The content of health education included face-to-face language explanation of the whole process of catheter knowledge, issuing catheter maintenance manual, issuing ordinary grip ball and telling how to use it, and follow-up.
|
|
Experimental: Experiment 1 set
Patients were routinely implanted with PICC, and the optimal duration-relaxation time of grip strength training was adopted on the basis of health education in the control group.
|
Patients were routinely implanted with PICC, and on the basis of health education in the control group, the best continuous-relaxation time, frequency and maximum grip strength of patients were used for grip strength training.
|
|
Experimental: Experiment 2 set
On the basis of control group
|
First determine patients for holding the ball movement should reach the effective blood flow velocity and best duration - relaxation, and USES the electronic grips and color doppler ultrasonic diagnostic apparatus, for individual patients to choose the best grip the efforts and training, to form the best grip the training plan, and observe the scheme for Peripheral central venous catheter-associated thrombosis prevention effect.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of Peripheral central venous catheter-associated thrombosis in patients with PICC tube
Time Frame: 8 weeks
|
Before catheterization, 24 hours after catheterization, and weekly maintenance, color Doppler ultrasound diagnostic instrument was used to diagnose venous thrombosis (including asymptomatic thrombosis) and its classification.
The patients were observed for 8 weeks.
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hemodynamic changes of the patient
Time Frame: 8 weeks
|
During weekly maintenance, color Doppler ultrasound was used to measure the blood velocity of the arm axillary vein on the side of the catheter, and the maximum blood velocity (Vmax, cm/s) was recorded.
|
8 weeks
|
|
Analysis of the influencing factors of Peripheral central venous catheter-associated thrombosis formation
Time Frame: 8 weeks
|
By investigating the baseline data of patients, the related factors affecting the formation of PICC-CRT in patients with tumor tube in the baseline data of the same group were analyzed and compared.
|
8 weeks
|
|
Patients' satisfaction with health education after PICC catheterization
Time Frame: 8 weeks
|
At the end of the intervention, the patients' attitude towards PICC catheterization health education questionnaire (self-made) was distributed to the study subjects, and the satisfaction of the study subjects with the health education after PICC catheterization was learned through the questionnaire.
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Junyan Zhao, Master, Qianfoshan Hospital
- Principal Investigator: Yuanjing Qiao, Master, Shandong University of Traditional Chinese Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 10, 2022
Primary Completion (Anticipated)
December 31, 2022
Study Completion (Anticipated)
January 10, 2023
Study Registration Dates
First Submitted
August 24, 2022
First Submitted That Met QC Criteria
December 1, 2022
First Posted (Estimate)
December 6, 2022
Study Record Updates
Last Update Posted (Estimate)
December 6, 2022
Last Update Submitted That Met QC Criteria
December 1, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- YXLL-KY-2022(057)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stomach Cancer
-
Ohio State University Comprehensive Cancer CenterPharmacia and UpjohnCompletedStomach Cancer | Esophageal Cancer | Cancer of Stomach | Esophagus CancerUnited States
-
Chinese University of Hong KongUnknown
-
Chinese University of Hong KongUnknown
-
BayerCompletedPrevention of Oesophagus Cancer and Stomach CancerUnited Kingdom
-
Gangnam Severance HospitalCompletedStomach Cancer | Colorectal Cancer | Pancreatobiliary CancerKorea, Republic of
-
Essen BiotechRecruitingStomach Cancer | Esophageal Cancer | Stomach Cancer, Adenocarcinoma | Stomach Cancer Recurrent | Esophageal Cancer Metastatic to Bone | Esophageal Cancer Metastatic to Lung | Esophageal Cancer Metastatic to LiverChina
-
Chinese University of Hong KongRecruiting
-
Xijing Hospital of Digestive DiseasesCompletedStomach Cancer | Esophageal Cancer | Esophageal Dysplasia | Stomach DysplasiaChina
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; SCRI Development Innovations... and other collaboratorsCompletedStomach Cancer | Gastric Cancer | Esophageal CancerUnited States
-
MacroGenicsMerck Sharp & Dohme LLCCompletedStomach Cancer | Gastric Cancer | Esophageal CancerKorea, Republic of, United States, Taiwan, Singapore, Canada
Clinical Trials on Health education on routine grip strength training
-
Yuanjiao YanCompletedChronic Obstructive Pulmonary Disease (COPD)China
-
Central Taiwan University of Science and TechnologyCompletedDementia | Aging | Elderly | Physical DisabilityTaiwan
-
Alexandria UniversityCompleted
-
Lingshu SunActive, not recruiting
-
Ankara UniversityNot yet recruiting
-
Junyan ZhaoActive, not recruitingTumor Chemotherapy PatientsChina
-
Necmettin Erbakan UniversityCompleted
-
Tianjin HospitalCompletedLumbar Disc HerniationChina
-
Children's Hospital of Fudan UniversityNot yet recruiting
-
Tungs' Taichung Metroharbour HospitalRecruitingDepression | Breast Cancer | AnxietyTaiwan